These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14672069)

  • 1. BMS issues PK notice regarding ATV + TDF.
    IAPAC Mon; 2003 Sep; 9(9):203. PubMed ID: 14672069
    [No Abstract]   [Full Text] [Related]  

  • 2. Atazanavir (Reyataz): new recommendations if combined with tenofovir (Viread) -- and warning on Viagra, Cialis, and Levitra.
    AIDS Treat News; 2004 Mar; (399):5. PubMed ID: 15199867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of switching unboosted atazanavir coadministered with tenofovir disoproxil fumarate from 400 mg once daily to 200 mg twice daily in HIV-positive patients.
    Bonora S; Gonzalez de Requena D; D'Avolio A; Calcagno A; Tettoni M; Siccardi M; Baietto L; Simiele M; Trentini L; Di Perri G
    Antivir Ther; 2011; 16(4):499-504. PubMed ID: 21685537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 96-week CASTLE data show similar efficacy results.
    AIDS Patient Care STDS; 2008 Nov; 22(11):918. PubMed ID: 19043840
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA notifications. BMS issues letter about omeprazole.
    AIDS Alert; 2005 Apr; 20(4):45-6. PubMed ID: 15841529
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA approves Viread for HIV-1 infection.
    FDA Consum; 2002; 36(1):5. PubMed ID: 11881601
    [No Abstract]   [Full Text] [Related]  

  • 7. Tenofovir: Gilead applies for approval; expanded access liberalized.
    Gilden D
    AIDS Treat News; 2001 May; (364):2-3, 1. PubMed ID: 11569959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viread gets FDA nod.
    Rodriquez E
    Posit Living; 2001 Dec-2002 Jan; 10(7):33. PubMed ID: 11808509
    [No Abstract]   [Full Text] [Related]  

  • 9. [HIV therapy: tenofir DF is available in 68 developing countries at production costs price].
    Med Klin (Munich); 2003 Jul; 98(7):XV-XVI. PubMed ID: 12945544
    [No Abstract]   [Full Text] [Related]  

  • 10. Gilead sciences releases Viread.
    Giles C
    Surviv News (Atlanta Ga); 2002 Jan; ():15. PubMed ID: 11870987
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA notifications. Reyataz is approved for HIV treatment.
    AIDS Alert; 2003 Sep; 18(9):119-20. PubMed ID: 14686309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenofovir coadministration is not associated with lower unboosted atazanavir plasma exposure in the clinical setting.
    Calcagno A; Bonora S; Tettoni MC; D'Avolio A; Perri GD; Lanzafame M; Penco G
    J Acquir Immune Defic Syndr; 2009 Nov; 52(3):431-2. PubMed ID: 19858926
    [No Abstract]   [Full Text] [Related]  

  • 13. Atazanavir gets FDA Advisory Committee's thumbs-up.
    IAPAC Mon; 2003 Jun; 9(6):120. PubMed ID: 12951939
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of modelling intra-subject variability on tests based on non-linear mixed-effects models in cross-over pharmacokinetic trials with application to the interaction of tenofovir on atazanavir in HIV patients.
    Panhard X; Taburet AM; Piketti C; Mentré F
    Stat Med; 2007 Mar; 26(6):1268-84. PubMed ID: 16810714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenofovir: FDA hearing October 3, public comment deadlines September 26.
    James JS
    AIDS Treat News; 2001 Aug; (370):3-4. PubMed ID: 11570163
    [No Abstract]   [Full Text] [Related]  

  • 16. Tenofovir DF on the horizon. Investigational nucleotide reverse transcriptor inhibitor could be on pharmacy shelves soon.
    Eagan L
    Posit Living; 2001; 10(5):21. PubMed ID: 11693102
    [No Abstract]   [Full Text] [Related]  

  • 17. Generic Truvada approved.
    AIDS Patient Care STDS; 2009 May; 23(5):395. PubMed ID: 19422066
    [No Abstract]   [Full Text] [Related]  

  • 18. [Once daily administration improves therapy adherence in HAART. New substance class with more powerful reserves against virus resistance].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():86-9. PubMed ID: 11373792
    [No Abstract]   [Full Text] [Related]  

  • 19. [Simply convincing. New fixed combination for HIV therapy].
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():20-3. PubMed ID: 16385865
    [No Abstract]   [Full Text] [Related]  

  • 20. High rate of virologic failure with once-daily ddI/3TC/TDF.
    IAPAC Mon; 2003 Nov; 9(11):279. PubMed ID: 14989185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.